MAB1965
antibody from Novus Biologicals
Targeting: IL24
C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB1965 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Mouse Monoclonal IL-24 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects human IL-24 in direct ELISAs and Western blots.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 500 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells.
Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells.
Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.
Zhu Y, Lv H, Xie Y, Sheng W, Xiang J, Yang J
Cancer gene therapy 2011 Sep;18(9):627-36
Cancer gene therapy 2011 Sep;18(9):627-36
Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells.
Maarof G, Bouchet-Delbos L, Gary-Gouy H, Durand-Gasselin I, Krzysiek R, Dalloul A
Blood 2010 Mar 4;115(9):1718-26
Blood 2010 Mar 4;115(9):1718-26
Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.
Qian W, Liu J, Tong Y, Yan S, Yang C, Yang M, Liu X
Leukemia 2008 Feb;22(2):361-9
Leukemia 2008 Feb;22(2):361-9
No comments: Submit comment
No validations: Submit validation data